AKERS BIOSCIENCES, INC. (NASDAQ:AKER) Files An 8-K Other Events
Item 8.01 Other Events.
A hearing to determine whether to approve a proposed class action settlement concerning certain purchasers of the shares of Akers Biosciences, Inc. common stock, no par value, originally scheduled for November 8, 2019 at 2:30 P.M. New York Time, has been rescheduled. The hearing will be held on December 20, 2019, at 11 A.M New York Time, before the Honorable Esther Salas, United States District Judge of the District of New Jersey, Martin Luther King Building & U.S. Courthouse, 50 Walnut Street, Courtroom 5A, Newark, New Jersey 07101.
If you have any questions about the Settlement, you may call or write to Lead Counsel or to the Claims Administrator:
THE ROSEN LAW FIRM, P.A.
Laurence M. Rosen, Esq.
609 W. South Orange Avenue, Suite 2P
South Orange, NJ 07079
Tel: (973) 313-1887
Fax: (973) 833-0399
Akers Biosciences, Inc. Securities Litigation
c/o Strategic Claims Services
P.O. Box 230
600 N. Jackson St., Ste. 205
Media, PA 19063
Tel.: 866-274-4004
Fax: 610-565-7985
